Avelumab: New Agent Available for Merkel Cell Carcinoma

Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey discusses the use of avelumab, a new agent that became available for patients with merkel cell carcinoma. This was recorded at the... Author: aacr2017 Added: 04/27/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts